David Amrol to Adolescent
This is a "connection" page, showing publications David Amrol has written about Adolescent.
Connection Strength
0.065
-
Soluble CD23 and interleukin-1 receptor antagonist in human asthmatics following antigen challenge. J Asthma. 2005 Feb; 42(1):73-6.
Score: 0.025
-
Topical pimecrolimus in the treatment of human allergic contact dermatitis. Ann Allergy Asthma Immunol. 2003 Dec; 91(6):563-6.
Score: 0.023
-
Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency. J Clin Invest. 2018 07 02; 128(7):3071-3087.
Score: 0.016